Cite
HARVARD Citation
Tan, H. et al. (2013). Dose Response and Pharmacokinetics of Tofacitinib (CP‐690, 550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis. CPT: pharmacometrics & systems pharmacology. pp. 1-8. [Online].